$7.65 Billion is the total value of HHLR ADVISORS, LTD.'s 85 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| EDU | Exit | NEW ORIENTAL ED & TECHNOLOGYspon adr | $0 | – | -78,771 | -100.0% | -0.01% | – |
| DGNRU | Exit | DRAGONEER GROWTH OPPORTUNITY COunit 08/18/2027 | $0 | – | -200,000 | -100.0% | -0.02% | – |
| HOOK | Exit | HOOKIPA PHARMA INC | $0 | – | -269,368 | -100.0% | -0.02% | – |
| Exit | CYTOKINETICS INC | $0 | – | -230,718 | -100.0% | -0.05% | – | |
| CJJD | Exit | CHINA JO-JO DRUGSTORES INC | $0 | – | -4,840,000 | -100.0% | -0.05% | – |
| NTES | Exit | NETEASE INCsponsored ads | $0 | – | -43,500 | -100.0% | -0.05% | – |
| MAACU | Exit | MONTES ARCHIMEDES ACQUISITIOunit 09/30/2025 | $0 | – | -500,000 | -100.0% | -0.06% | – |
| LPTX | Exit | LEAP THERAPEUTICS INC | $0 | – | -3,575,745 | -100.0% | -0.06% | – |
| COGT | Exit | COGENT BIOSCIENCES INC | $0 | – | -1,000,000 | -100.0% | -0.08% | – |
| NKTX | Exit | NKARTA INC | $0 | – | -277,778 | -100.0% | -0.09% | – |
| RNA | Exit | AVIDITY BIOSCIENCES INC | $0 | – | -425,000 | -100.0% | -0.11% | – |
| IGMS | Exit | IGM BIOSCIENCES INC | $0 | – | -151,390 | -100.0% | -0.13% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -650,000 | -100.0% | -0.14% | – |
| OLMA | Exit | OLEMA PHARMACEUTICALS INC | $0 | – | -620,397 | -100.0% | -0.18% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -360,000 | -100.0% | -0.25% | – |
| AAPL | Exit | APPLE INC | $0 | – | -200,000 | -100.0% | -0.28% | – |
| GDS | Exit | GDS HLDGS LTDsponsored ads | $0 | – | -390,000 | -100.0% | -0.32% | – |
| DIDI | Exit | DIDI GLOBAL INCsponsored ads | $0 | – | -3,016,060 | -100.0% | -0.44% | – |
| OTIS | Exit | OTIS WORLDWIDE CORP | $0 | – | -614,556 | -100.0% | -0.52% | – |
| BPMC | Exit | BLUEPRINT MEDICINES CORP | $0 | – | -635,302 | -100.0% | -0.58% | – |
| KOD | Exit | KODIAK SCIENCES INC | $0 | – | -810,207 | -100.0% | -0.78% | – |
| FGEN | Exit | FIBROGEN INC | $0 | – | -3,955,787 | -100.0% | -1.08% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -2,929,708 | -100.0% | -1.91% | – |
| ZM | Exit | ZOOM VIDEO COMMUNICATION INcl a | $0 | – | -1,027,400 | -100.0% | -4.09% | – |
| ESGR | Exit | ENSTAR GROUP LIMITED | $0 | – | -1,747,840 | -100.0% | -4.30% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-15
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| BEIGENE LTD | 23 | Q2 2024 | 26.0% |
| JD.COM INC | 23 | Q2 2024 | 13.1% |
| SOHU COM LTD | 23 | Q2 2024 | 0.6% |
| PINDUODUO INC | 22 | Q2 2024 | 29.8% |
| MONDELEZ INTL INC | 22 | Q1 2024 | 5.9% |
| GOSSAMER BIO INC | 22 | Q2 2024 | 2.3% |
| IQIYI INC | 21 | Q4 2023 | 12.3% |
| BRIDGEBIO PHARMA INC | 21 | Q2 2024 | 3.4% |
| KINIKSA PHARMACEUTICALS LTD | 21 | Q1 2024 | 1.6% |
| ALIBABA GROUP HLDG LTD | 20 | Q2 2024 | 9.6% |
View HHLR ADVISORS, LTD.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Agora, Inc. | February 14, 2024 | 19,287,300 | 5.1% |
| Aligos Therapeutics, Inc. | February 14, 2024 | 5,971,426 | 8.2% |
| Bright Scholar Education Holdings Ltd | February 14, 2024 | 3,952,572 | 12.6% |
| Cytek Biosciences, Inc. | February 14, 2024 | 6,657,030 | 4.9% |
| Kiniksa Pharmaceuticals, Ltd. | February 14, 2024 | 3,879,426 | 9.9% |
| MOGU Inc. | February 14, 2024 | 254,253,005 | 11.8% |
| Smart Share Global Ltd | February 14, 2024 | 62,367,293 | 14.0% |
| I-Mab | June 30, 2023 | 15,891,211 | 8.3% |
| BeiGene, Ltd. | February 14, 2023 | 147,043,058 | 10.9% |
| Gossamer Bio, Inc. | February 14, 2023 | 4,974,041 | 5.3% |
View HHLR ADVISORS, LTD.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View HHLR ADVISORS, LTD.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.